Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Alnylam Q4 2025: Gewinn pro Aktie übertrifft Erwartungen, Umsatz verfehlt Prognose (Investing.com DE) +++ ALNYLAM Aktie -3,63%

Gewinn & Umsatz News zur WEST PHARMACEUTICAL Aktie

 >WEST PHARMA Aktienkurs 
206.25 EUR    (TradegateBSX)
Ask: 206.8 EUR / 72 Stück
Bid: 205.7 EUR / 72 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
WEST PHARMA Aktie über LYNX handeln
>WEST PHARMA Performance
1 Woche: +4,7%
1 Monat: -12,1%
3 Monate: -10,9%
6 Monate: -0,8%
1 Jahr: -32,3%
laufendes Jahr: -10,3%
>WEST PHARMACEUTICAL Aktie
Name:  WEST PHARMACEUTICAL SERVICES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US9553061055 / 864330
Symbol/ Ticker:  WPS (Frankfurt) / WST (NYSE)
Kürzel:  FRA:WPS, ETR:WPS, WPS:GR, NYSE:WST
Index:  S&P500
Webseite:  https://www.westpharma.co..
Profil:  West Pharmaceutical Services, Inc. is a leading pr..
>Volltext..
Marktkapitalisierung:  15050.17 Mio. EUR
Unternehmenswert:  14772.45 Mio. EUR
Umsatz:  2535.58 Mio. EUR
EBITDA:  668.94 Mio. EUR
Nettogewinn:  413.21 Mio. EUR
Gewinn je Aktie:  5.71 EUR
Schulden:  254.63 Mio. EUR
Liquide Mittel:  528.18 Mio. EUR
Operativer Cashflow:  583.05 Mio. EUR
Bargeldquote:  0.99
Umsatzwachstum:  -0.47%
Gewinnwachstum:  -6.62%
Dividende je Aktie:  0.73 EUR
Dividendenrendite:  0.35%
Dividendenschätzung:  0.35%
Div. Historie:  28.01.26 - 0.184118€
12.11.25 - 0.18900199€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  WEST PHARMACEUTICAL, WEST PHARMA, WEST PHARMACEUTICALS
Letzte Datenerhebung:  12.02.26
>WEST PHARMA Kennzahlen
Aktien/ Unternehmen:
Aktien: 71.94 Mio. St.
Frei handelbar: 99.38%
Rückkaufquote: 0.96%
Mitarbeiter: 10600
Umsatz/Mitarb.: 0.23 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 37.64%
Bewertung:
KGV: 35.79
KGV lG: 34.08
KUV: 5.61
KBV: 5.69
PEG-Ratio: 237.56
EV/EBITDA: 22.08
Rentabilität:
Bruttomarge: 35.59%
Gewinnmarge: 16.3%
Operative Marge: 20.91%
Managementeffizenz:
Gesamtkaprendite: 12.64%
Eigenkaprendite: 16.94%
>WEST PHARMA Peer Group
Gesundheit
 
12.02.26 - 12:54
West Pharmaceutical Q4 Earnings Rise; Guides FY26 (AFX)
 
WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST), on Thursday, reported its higher net income in the fourth quarter compared with the previous year and issued an outlook for the ful......
15.01.26 - 14:24
Earnings Preview: What to Expect From West Pharmaceutical Services' Report (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
23.10.25 - 12:42
West Pharmaceutical Services Inc. Q3 Profit Increases, Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - West Pharmaceutical Services Inc. (WST) revealed a profit for its third quarter that Increased from last year and beat the Street estimates.The company's bottom line totaled......
07.10.25 - 13:24
West Pharmaceutical Services′ Quarterly Earnings Preview: What You Need to Know (Barchart)
 
West Pharmaceutical Services will release its third-quarter earnings soon, and analysts anticipate a high single-digit profit dip....
24.07.25 - 13:18
West Pharma Q2 Profit Rises; Lifts FY25 Outlook; Stock Up In Pre-market (AFX)
 
WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST), a designer and manufacturer of injectable pharmaceutical packaging and delivery systems, on Thursday announced that net income incr......
24.07.25 - 13:01
West Pharmaceutical Services Inc. Q2 Profit Increases, Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - West Pharmaceutical Services Inc. (WST) revealed a profit for its second quarter that Increased from the same period last year and beat the Street estimates.The company's ea......
07.07.25 - 09:54
West Pharmaceutical Services′ Q2 2025 Earnings: What to Expect (Barchart)
 
West Pharmaceutical Services is expected to announce its second-quarter results later this month, with analysts projecting a marginal drop in its bottom line....
27.05.25 - 13:48
West Pharmaceutical Stock: Analyst Estimates & Ratings (Barchart)
 
West Pharmaceutical stock has notably lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock's prospects....
24.04.25 - 12:55
West Pharmaceutical Services Inc. Q1 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - West Pharmaceutical Services Inc. (WST) revealed a profit for first quarter that decreased from last year but beat the Street estimates.The company's bottom line totaled $89......
11.04.25 - 14:36
West Pharmaceutical Services Earnings Preview: What to Expect (Barchart)
 
West Pharmaceutical Services will release its first-quarter earnings later this month, and analysts anticipate a double-digit profit dip....
13.02.25 - 12:30
West Pharmaceutical Services Inc. Q4 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - West Pharmaceutical Services Inc. (WST) announced a profit for fourth quarter that decreased from last year but beat the Street estimates.The company's earnings came in at $......
22.01.25 - 09:30
What You Need to Know Ahead of West Pharmaceutical Services′ Earnings Release (Barchart)
 
West Pharmaceutical Services is expected to announce its fourth-quarter results in the upcoming month and analysts expect a single-digit drop in earnings....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Mag alles Leid und Schatten sein - doch diese süße Sonnenstunde nicht, und nicht der Duft vom roten Klee, und nicht das tiefe, zarte Wohlgefühl in meiner Seele. - Hermann Hesse
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!